clc dna workbench software (CLC Bio)
90
Structured Review
CLC Bio
clc dna workbench software
Clc Dna Workbench Software, supplied by CLC Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+program+for+dna+sequencing/clc+dna+workbench/pmc04015844-283-5-9
Average 90 stars, based on 1 article reviews
Clc Dna Workbench Software, supplied by CLC Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+program+for+dna+sequencing/clc+dna+workbench/pmc04015844-283-5-9
Average 90 stars, based on 1 article reviews
clc dna workbench software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Phenotypic spectrum of the first Belgian MYBPC3 founder: a large multi-exon deletion with a varying phenotype Article Snippet: Sanger sequencing was used to sequence the resulting PCR product (3500 Dx Genetic Analyzer, Applied Biosystems) and sequence was compared to the reference sequence ENST00000545968.6 retrieved from Ensembl ( ) using Article Title: Two Leishmania species separation targeting the ITS-rDNA and Cyt b genes by developing and evaluating HRM- qPCR Article Snippet: The Article Title: Two Leishmania species separation targeting the ITS-rDNA and Cyt b genes by developing and evaluating HRM- qPCR Article Snippet: After cloning the Genomic Sequencing:Article Title: Characterization of potential spermatogonia biomarker genes in the European eel (Anguilla anguilla). Article Snippet: Identification of vasa1, vasa2, nanos2, and dnd1 sequences from European and Japanese eel genome datasets The vasa1, vasa2, nanos2, and dnd1 sequences in vertebrate species were retrieved from NCBI (http:// www. ncbi. nlm. nih. gov/) and Ensembl (https:// www. ensem bl. org/ index. html) databases. .. All the genomic sequences of vasa1, vasa2, nanos2, and dnd1 were retrieved from European (Anguilla anguilla; for accession/ID number GCF_013347855.1) (Henkel et al. 2012a) and Japanese eel (Anguilla japonica) genomes by performing the TBLASTN algorithm of the Software:Article Title: Characterization of potential spermatogonia biomarker genes in the European eel (Anguilla anguilla). Article Snippet: Identification of vasa1, vasa2, nanos2, and dnd1 sequences from European and Japanese eel genome datasets The vasa1, vasa2, nanos2, and dnd1 sequences in vertebrate species were retrieved from NCBI (http:// www. ncbi. nlm. nih. gov/) and Ensembl (https:// www. ensem bl. org/ index. html) databases. .. All the genomic sequences of vasa1, vasa2, nanos2, and dnd1 were retrieved from European (Anguilla anguilla; for accession/ID number GCF_013347855.1) (Henkel et al. 2012a) and Japanese eel (Anguilla japonica) genomes by performing the TBLASTN algorithm of the Article Title: Proprotein convertase subtilisin/kexin type 9 genetic screening using the vervet (Chlorocebus aethiops) model. Article Snippet: Cardiovascular diseases (CVDs) remain one of the principal causes for mortality globally, and this includes several diseases such as ischemic heart diseases, venous thromboembolism, and stroke.1 Central to the development of these CVD disorders is atherosclerosis, which occurs due to the accumulation of lowdensity lipoprotein cholesterol (LDLC) in the inner layer of the arterial wall,2 and the buildup of cholesterol in macrophages due to the insufficient elimination of LDLs, fats, and cholesterol by active highdensity lipoprotein.3,4 The contribution of environmental factors (diet or smoking) to the development of atherosclerosis cannot be overplayed, however, genetic factors are more significant determinants of the risk of atherosclerotic CVD.5 Additionally, the emergence of genomewide association studies has revealed that genes play a substantial role in the development of CVDs.6 The proprotein convertase subtilisin/ kexin type 9 (PCSK9) gene has attracted interest due to its reported role in the clearance of LDLs.7 This gene is expressed in several organs, particularly the liver, small intestines, and the kidney,8 where it is suggested to posttranscriptionally regulate the number of cell surface LDL receptors (LDLR) thereby regulating the plasma levels of LDLC.9,10 The PCSK9 molecule is recognized as the main controller for LDLR activity and a viable drug target for the treatment of hypercholesterolemia.8,11,12,13 A sequence variant (E670G) of PCSK9 was reported to be a significant determining factor of plasma LDLC levels and was linked to the development of severe coronary atherosclerosis14 and largevessel atherosclerosis stroke.15 Studies conducted after the discovery of PCSK9 further revealed the importance of sterol regulatory elementbinding protein2 (SREBP2) in the regulation of cholesterol metabolism.1618 Article Title: Molecular Evidence for the Thriving of Campylobacter jejuni ST-4526 in Japan Article Snippet: For the sequencing reactions, we used both DNA strands in each allele with the BigDye terminator v. 3.1 Ready Reaction Cycle Sequencing kit on an ABI3730x DNA analyzer (Life technologies). .. The obtained sequences were assembled using Sequencing:Article Title: Proprotein convertase subtilisin/kexin type 9 genetic screening using the vervet (Chlorocebus aethiops) model. Article Snippet: Cardiovascular diseases (CVDs) remain one of the principal causes for mortality globally, and this includes several diseases such as ischemic heart diseases, venous thromboembolism, and stroke.1 Central to the development of these CVD disorders is atherosclerosis, which occurs due to the accumulation of lowdensity lipoprotein cholesterol (LDLC) in the inner layer of the arterial wall,2 and the buildup of cholesterol in macrophages due to the insufficient elimination of LDLs, fats, and cholesterol by active highdensity lipoprotein.3,4 The contribution of environmental factors (diet or smoking) to the development of atherosclerosis cannot be overplayed, however, genetic factors are more significant determinants of the risk of atherosclerotic CVD.5 Additionally, the emergence of genomewide association studies has revealed that genes play a substantial role in the development of CVDs.6 The proprotein convertase subtilisin/ kexin type 9 (PCSK9) gene has attracted interest due to its reported role in the clearance of LDLs.7 This gene is expressed in several organs, particularly the liver, small intestines, and the kidney,8 where it is suggested to posttranscriptionally regulate the number of cell surface LDL receptors (LDLR) thereby regulating the plasma levels of LDLC.9,10 The PCSK9 molecule is recognized as the main controller for LDLR activity and a viable drug target for the treatment of hypercholesterolemia.8,11,12,13 A sequence variant (E670G) of PCSK9 was reported to be a significant determining factor of plasma LDLC levels and was linked to the development of severe coronary atherosclerosis14 and largevessel atherosclerosis stroke.15 Studies conducted after the discovery of PCSK9 further revealed the importance of sterol regulatory elementbinding protein2 (SREBP2) in the regulation of cholesterol metabolism.1618 |